FDA announces actions to accelerate drug development

• GlobalRPh publishes a weekly medical news roundup, reviewing developments from the FDA, CDC, WHO, NIH, and major medical journals for the week of September 11-17, 2026. • The roundup covers clinically important developments from these sources, aiming to inform healthcare professionals about changes that may affect clinical practice, medication management, and public health response.

• A test manufacturer has announced that its product can detect over 50 types of cancer in individuals aged 50 and older. • The test's ability to detect more than 50 types of cancer is a significant figure that highlights its potential to improve health outcomes for older adults.

• The National Center for Health Statistics is the nation's official source for health data in the United States. • The organization has an official government website with a .gov domain, indicating it is a secure site for sharing sensitive information.

• Public health in the US has experienced a decline in trust due to its handling of disease outbreaks, including COVID-19, and related policies such as mandates and censorship. • The field of public health is defined as the organized effort to protect and improve community health through disease prevention, education, and safety standards, which is distinct from clinical medicine that focuses on individual patient care.

• The U.S. Food and Drug Administration approved a combination of the oral drugs WELIREG and LENVIMA for adult patients with advanced clear cell renal cell carcinoma who have received prior treatment. • This approval follows the Phase 3 LITESPARK-011 trial, which compared the dual regimen against the drug cabozantinib.

• NBC News is tracking confirmed measles case counts and state infection tallies across the U.S. through a dedicated map. • Measles case counts reached a 34-year high in 2025 and have increased further in 2026.

• Happy Health launched a clinical-grade smart ring called Happy Ring after receiving U.S. Food and Drug Administration approval in October 2024. • The company's Happy Sleep platform integrates the wearable device with a clinical care team of board-certified sleep physicians.

• The US Food and Drug Administration is expected to announce measures in the coming days to accelerate the approval process for nicotine pouches and vaping products. • The agency plans to revisit a 2021 rule that outlines the specific requirements for new tobacco applications.

• Measles outbreaks have recently documented hundreds of cases across Pennsylvania, South Carolina, Texas, and Utah. • Most of the reported infections have occurred among people who are unvaccinated.

• Beacon Therapeutics announced on Monday that its experimental gene therapy improved reading ability in low-light conditions during a late-stage trial for people with an inherited eye disease. • The therapy targeted a specific condition that causes progressive vision loss and successfully met its primary trial goal.

• The Medical Counselling Committee (MCC) will open Round 3 registrations for the National Eligibility and Entrance Test-Undergraduate (NEET UG) on September 22. • This registration phase applies to candidates seeking admission to MBBS, BDS, and B.Sc Nursing courses for the 2026 academic year.

• The Centre for Cell Therapy and Regenerative Medicine announced that stem cell therapy for autism must only be conducted within approved clinical trials. • Dr. Dinesh Arab noted that new, sophisticated drugs have failed to reduce the overall incidence of heart attacks and strokes.